Quintiles Advanced Phase Solutions

"Quintiles Advanced Phase Solutions" does not appear to be a distinct standalone biotech or pharma company with its own drug pipeline. The name most plausibly refers to a Quintiles business line or descriptive label associated with Quintiles' advanced, late-phase, or real-world research services rather than a separate legal entity. Quintiles was a major contract research organization serving biopharma clients across clinical development, post-approval studies, and real-world evidence generation. In October 2016, Quintiles merged with IMS Health to form QuintilesIMS, which was later renamed IQVIA in November 2017. Accordingly, the requested name is best treated as a historical or business-unit-style reference within the broader Quintiles/IQVIA organization rather than an independent operating company.